Prevalence and sonographic changes compatible with fatty liver disease in patients referred for abdominal ultrasound examination in Aracaju, SE

Cruz, Josilda Ferreira; Cruz, María; Neto, José Machado Moita; Santana, Demetrius Silva de; Oliveira, Cristiane Costa da Cunha; Lima, Sônia Oliveira

doi:10.1590/0100-3984.2014.0124

Cited by 11 publications

(4 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of NAFLD worldwide is estimated to be approximately 25%[ 17 ]. In a 2016 study conducted in Brazil in an age group similar to our study, a total of 800 people (561 women and 239 men) were examined, and the prevalence of steatosis was found to be 29.1% and higher in men than in women[ 18 ]. According to 2016 data published by WHO, Turkey is the country with the highest obesity prevalence (32.1%) in Europe[ 17 ].…”

Section: Discussionmentioning

confidence: 86%

Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients

Tahtabaşı¹,

Hoşbul²,

Karaman³

et al. 2021

WJCCM

View full text Add to dashboard Cite

BACKGROUND Recent studies of the coronavirus disease 2019 (COVID-19) demonstrated that obesity is significantly associated with increased disease severity, clinical outcome, and mortality. The association between hepatic steatosis, which frequently accompanies obesity, and the pneumonia severity score (PSS) evaluated on computed tomography (CT), and the prevalence of steatosis in patients with COVID-19 remains to be elucidated. AIM To assess the frequency of hepatic steatosis in the chest CT of COVID-19 patients and its association with the PSS. METHODS The chest CT images of 485 patients who were admitted to the emergency department with suspected COVID-19 were retrospectively evaluated. The patients were divided into two groups as COVID-19-positive [CT- and reverse transcriptase-polymerase chain reaction (RT-PCR)-positive] and controls (CT- and RT-PCR-negative). The CT images of both groups were evaluated for PSS as the ratio of the volume of involved lung parenchyma to the total lung volume. Hepatic steatosis was defined as a liver attenuation value of ≤ 40 Hounsfield units (HU). RESULTS Of the 485 patients, 56.5% ( n = 274) were defined as the COVID-19-positive group and 43.5% ( n = 211) as the control group. The average age of the COVID-19-positive group was significantly higher than that of the control group (50.9 ± 10.9 years vs 40.4 ± 12.3 years, P < 0.001). The frequency of hepatic steatosis in the positive group was significantly higher compared with the control group (40.9% vs 19.4%, P < 0.001). The average hepatic attenuation values were significantly lower in the positive group compared with the control group (45.7 ± 11.4 HU vs 53.9 ± 15.9 HU, P < 0.001). Logistic regression analysis showed that after adjusting for age, hypertension, diabetes mellitus, overweight, and obesity there was almost a 2.2 times greater odds of hepatic steatosis in the COVID-19-positive group than in the controls (odds ratio 2.187; 95% confidence interval: 1.336-3.580, P < 0.001). CONCLUSION The prevalence of hepatic steatosis was significantly higher in COVID-19 patients compared with controls after adjustment for age and comorbidities. This finding can be easily assessed on chest CT images.

show abstract

Section: Discussionmentioning

confidence: 86%

Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients

Tahtabaşı¹,

Hoşbul²,

Karaman³

et al. 2021

WJCCM

View full text Add to dashboard Cite

show abstract

“…In addition to that, the severity of the FLDcan also be evaluated with the help of ultrasound based on the degree of attenuation of beam and the loss of echoes from portal vein walls [7,8]. Ultrasonography holds a special significance in the detection of NAFLD as it can diagnose the disease in asymptomatic patients and is relatively simple, cheap and have minimum side effects [9]. CT utilizes Xrays to diagnose pathologies within the patient's body.…”

Section: Introductionmentioning

confidence: 99%

Association of sonographic grading of fatty liver disease with liver function tests and CT hounsfield

Bhardava

Agrawal²,

Patel

et al. 2022

ijhs

View full text Add to dashboard Cite

Fatty Liver Disease (FLD) is described as the accumulation of triglycerides within cytoplasmic vesicles of hepatocytes exceeding 5 percent of total liver weight. It is generally of two types: Alcoholic or Non-alcoholic FLD (NAFLD). It has a tendency to progress and cause steatohepatitis, brosis, cryptogenic cirrhosis, hepatocellular carcinoma, chronic liver disease, metabolic syndrome, polycystic ovarian syndrome and adenocarcinomas. Objective: To nd association of Sonographic Grading of Fatty Liver Disease with Liver Function Tests and CT Hounseld units. The evaluation of the signicance of Ultrasound and LFTs over Computed Tomography is the aim of this study for the diagnosis of Fatty Liver Disease. Method: patients were undergone CT exams, Ultrasound exams and LFT tests for this this study (mean age: Their hepatic Hounseld units were obtained, Ultrasonographic grades were specied and LFTs were recorded. Results: The sonographic grading of fatty liver is significant/ not, taking HU value as standard. Conclusion: It is concluded that Ultrasound is effective in diagnosing this disease in all grades of FattyLiver Disease along with Liver Function Tests.

show abstract

“…The increasing use of imaging examinations for abdominal evaluation and recent technical advances in radiology have led to an increase in the number of liver lesions detected. The evaluation of the liver by imaging methods has been the subject of a series of recent publications in the radiology literature of Brazil ( 1 - 10 ) . Most liver lesions are benign and can be diagnosed on the basis of their imaging characteristics ( 11 ) .…”

Section: Introductionmentioning

confidence: 99%

Fat-containing liver lesions: a pictorial review

et al. 2018

View full text Add to dashboard Cite

The aim of this pictorial essay is to review the spectrum of fat-containing liver lesions and their characterisation on magnetic resonance imaging with focus on the radiological features that aid in the differential diagnoses. Fat-containing liver lesions comprise a heterogeneous group of tumours with variable imaging findings. Magnetic resonance imaging clearly displays the micro- and macroscopic fat components of the lesions and other characteristic features that are helpful tools to make the differential diagnosis.

show abstract

Prevalence and sonographic changes compatible with fatty liver disease in patients referred for abdominal ultrasound examination in Aracaju, SE

Cited by 11 publications

References 30 publications

Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients

Frequency of hepatic steatosis and its association with the pneumonia severity score on chest computed tomography in adult COVID-19 patients

Association of sonographic grading of fatty liver disease with liver function tests and CT hounsfield

Fat-containing liver lesions: a pictorial review

Contact Info

Product

Resources

About